Welcome to our dedicated page for Stride SEC filings (Ticker: LRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Stride, Inc. (NYSE: LRN) SEC filings, giving investors and researchers a detailed view of how the technology-based education company reports its operations, governance, and risks. As a Delaware corporation listed on the New York Stock Exchange, Stride files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy statements on Schedule 14A with the U.S. Securities and Exchange Commission.
Annual and quarterly reports such as the Form 10-K for the fiscal year ended June 30, 2025 and subsequent Form 10-Q filings contain audited and interim financial statements, segment information for General Education and Career Learning, enrollment and revenue-per-enrollment data, and extensive risk factor discussions. These documents explain how Stride’s online K–12, career learning, and adult education programs contribute to revenue and outline key risks related to funding, regulation, technology, and competition.
Current reports on Form 8-K capture material events. Recent 8-K filings describe earnings releases for fiscal 2025 and the first quarter of fiscal 2026, the authorization of a stock repurchase program for up to a specified amount of common stock, Board changes including the election of an additional director, and stockholder approvals of an amended and restated 2016 Equity Incentive Award Plan and a 2025 Employee Stock Purchase Plan. These filings also summarize vote results from the 2025 Annual Meeting of Stockholders, including director elections, auditor ratification, and advisory votes on executive compensation.
Proxy materials such as the definitive proxy statement (DEF 14A) provide detail on corporate governance, Board structure, committee responsibilities, executive compensation programs, and equity incentive plans. They also describe stockholder proposals and voting requirements and reference the company’s annual report and financial statements.
On Stock Titan, Stride’s filings are updated as they are released on EDGAR, and AI-powered summaries help explain complex sections, such as non-GAAP reconciliations, compensation tables, and risk disclosures. Users can quickly review key points from lengthy 10-K and 10-Q reports, see how vote outcomes and plan approvals affect equity compensation, and track material events reported on Form 8-K, including capital allocation decisions and governance changes.
Investors interested in insider activity can also use this page to locate Forms 3, 4, and 5 when available, which report beneficial ownership and changes in holdings by Stride’s directors and executive officers. Together, these filings offer a comprehensive regulatory record of Stride, Inc.’s financial performance, governance practices, and significant corporate events.
Stride, Inc. furnished an 8-K stating it issued a press release announcing its financial results for the second quarter of fiscal 2026, which ended on December 31, 2025. The press release is included as Exhibit 99.1 and provides the detailed quarterly numbers and commentary. The company notes that this information, including Exhibit 99.1, is being furnished rather than filed, which limits its exposure to certain Exchange Act liabilities and affects how it may be incorporated by reference into future registration statements or reports.
Stride, Inc. executive McMullen Greerson Greene reported a tax‑withholding share transaction. On 09/15/2025, 324 shares of Stride common stock were withheld by the company at a price of $139.76 per share to cover the executive’s withholding taxes upon the vesting of restricted shares, after all vesting conditions were satisfied. Following this withholding transaction, Greene directly beneficially owned 13,102 shares of Stride common stock.
Stride, Inc. is registering 4,740,000 shares of common stock on a Form S-8 for employee benefit plans. This includes 740,000 additional shares that may be issued under the amended and restated 2016 Equity Incentive Award Plan and 4,000,000 shares that may be issued under the new 2025 Employee Stock Purchase Plan, both previously approved by stockholders on December 4, 2025. The company incorporates certain Exchange Act reports by reference and outlines standard undertaking and indemnification provisions for its directors and officers under Delaware law and its charter and bylaws.
A shareholder of LRN plans to sell 7,827 shares of common stock under Rule 144, with an aggregate market value of 500,404.37, through Morgan Stanley Smith Barney on the NYSE around 12/15/2025.
The shares come from restricted stock and performance share awards acquired from the issuer in 2017 and 2018. The notice references 43,858,627 common shares outstanding and includes a representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Stride, Inc. reported the results of its annual stockholder meeting held on December 4, 2025. Stockholders approved an amendment and restatement of the company’s 2016 Equity Incentive Award Plan, increasing the number of common shares available for equity awards by 740,000 and extending the plan’s term to October 17, 2035. They also approved a new 2025 Employee Stock Purchase Plan authorizing the issuance of 4,000,000 shares, allowing eligible employees to buy stock at a discount through payroll deductions.
All eight director nominees were elected, and KPMG LLP was ratified as independent auditor for the fiscal year ending June 30, 2026. On an advisory basis, stockholders approved compensation for named executive officers and supported both the updated equity plan and the new employee stock purchase plan by wide voting margins.
Stride, Inc. reported an equity award to one of its non-employee directors in the form of deferred stock units. On 12/04/2025, the director acquired 4,097 deferred stock units under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors at a price of $0 per unit. Each deferred stock unit is economically equivalent to one share of Stride common stock and becomes payable when the director’s board service ends. These new units will vest on the earlier of December 4, 2026, or the next annual meeting of Stride stockholders. Following this grant, the director beneficially owns 16,955 derivative securities in the form of deferred stock units, held directly.
Stride, Inc.December 4, 2025, the non-employee director received 4,097 Deferred Stock Units (DSUs) under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors. Each DSU is the economic equivalent of one share of Stride common stock, and any fractional shares will be settled in cash.
The DSUs will vest on the earlier of December 4, 2026 or the next annual meeting of Stride stockholders. After this award, the director beneficially owns 12,333 derivative securities, reported as held directly. The DSUs are payable when the director’s board service ends, so this grant defers compensation into equity aligned with the company’s share performance.
Stride, Inc. reported a routine insider transaction involving one of its directors. On December 4, 2025, the director acquired 4,097 shares of Stride common stock as a restricted stock award at a stated price of $0, reflecting an equity-based compensation grant rather than an open-market purchase.
After this grant, the director beneficially owns 6,359 shares of Stride common stock in direct ownership form. The filing notes that these restricted shares will vest on the earlier of December 4, 2026, or the next annual meeting of Stride’s stockholders, tying the award to continued board service and the company’s regular governance calendar.
Stride, Inc. reported that one of its directors received an award of 4,097 Deferred Stock Units (DSUs) on December 4, 2025 under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors. Each DSU is the economic equivalent of one share of Stride common stock and is payable after the director’s service ends, with any fractional share settled in cash.
The DSUs will vest on the earlier of December 4, 2026 or the next annual meeting of Stride’s stockholders. Following this grant, the director beneficially owns 13,218 derivative securities related to Stride common stock, held directly.
Stride, Inc. reported that a director received a grant of 4,097 shares of restricted common stock on December 4, 2025 at a price of $0 per share. Following this grant, the director beneficially owns 6,551 shares of Stride common stock in total, held directly. These restricted shares will vest on the earlier of December 4, 2026 or the next annual meeting of Stride’s stockholders, aligning the director’s compensation with the company’s future performance.